Product Description: Talviraline is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is primarily used to inhibit the replication of human immunodeficiency virus type 1 (HIV-1). Talviraline inhibits the viral replication process by binding to a specific site of HIV-1 reverse transcriptase (RT). Talviraline can be used to study the potential countermeasures and safety of HIV-1 infection[1].
Formula: C15H20N2O3S2
References: [1]Kleim J P, et al. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication[J]. Antimicrobial agents and chemotherapy, 1995, 39(10): 2253-2257.
CAS Number: 163451-80-7
Molecular Weight: 340.46
Research Area: Infection
Solubility: 10 mM in DMSO
Target: HIV;Reverse Transcriptase